Physician profile
Gilbert Seda
NPI 1568436350
$1,427.53
in general payments reported to CMS, 2019-2025
12 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $191 · 2021: $172 · 2022: $87.71 · 2023: $189 · 2024: $293 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545 · Education: $50.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.06 |
| Education | $50.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $552.99 | 2019-2025 | |
| Harmony Biosciences LLC | $204.88 | 2020-2022 | |
| Eisai INC. | $125.00 | 2019 | |
| Boston Scientific Corporation | $123.03 | 2019 | |
| Janssen Pharmaceuticals, INC | $116.45 | 2021 | |
| Inspire Medical Systems, INC. | $82.09 | 2023-2024 | Inspire |
| Resmed Corp | $73.18 | 2025 | |
| Axsome Therapeutics, INC. | $55.28 | 2023-2024 | Sunosi |
| Fisher & Paykel Healthcare INC | $31.91 | 2023-2024 | Fisher & Paykel Healthcare |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.74 | 2019-2020 | |
| Getinge USA Sales, LLC | $19.02 | 2025 | Cardiosave Rescue |
| Grifols USA, LLC | $14.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Seda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.